About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Boston | 1,052 Studies

Clinical Trials Breast CancerBoston

Breast Cancer Clinical Trials in Boston

Find 1,052 clinical trials for breast cancer near Boston, Massachusetts. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 381-400 of 1,052 trials

CompletedS0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing ChemoRATIONALE: Acetyl-L-carnitine may prevent or lessen neuropathy caused by chemotherapy.NCT00775645·Mobile, Alabama and 294 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingRadiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast CancerThis phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer.NCT03598257·Anchorage, Alaska and 219 others

RecruitingE-Mindfulness Approaches for Living After Breast CancerNRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a…NCT06748222·Phoenix, Arizona and 455 others

CompletedA Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsThis research study is done to test how well different types of cancer respond to the drug called larotrectinib.NCT02576431·Palo Alto, California and 97 others

CompletedLapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain MetastasesLapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth.NCT00098605·Boston, Massachusetts

Active not recruitingThe Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer PatientsThe objective of the study is to serve as a correlative study for patients enrolled on the RadCOMP trial (NCT02603341), a randomized phase III study of stage II and III breast…NCT03270072·Boston, Massachusetts

CompletedReal-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast CancerThe objective of this Phase II study is to assess the diagnostic accuracy of sentinel lymph node (SLN) identification in patients with breast cancer using near-infrared (NIR)…NCT01468649·Boston, Massachusetts

TerminatedStudy Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerIn this clinical research study, postmenopausal subjects with metastatic breast cancer will be given either the combination of temsirolimus (CCI-779) and letrozole or a placebo…NCT00083993·Hoover, Alabama and 128 others

CompletedZoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneRATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases.NCT00003884·Birmingham, Alabama and 54 others

CompletedWhole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerRSR13 (efaproxiral) is a radiation sensitizer that has shown positive results in a Phase 3, randomized clinical trial of patients with brain metastases.NCT00083304·Phoenix, Arizona and 93 others

UnknownFeasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer PatientsThis study aims to investigate the role of a mobile health app, Outcomes4Me, in the navigation of care for people with breast cancer.NCT04262518·Boston, Massachusetts

CompletedExercise Intervention in Women With Metastatic Breast CancerThis study is being done to evaluate the impact of moderate-intensity exercise (such as walking) on quality of life, energy level, endurance and mood in women with metastatic…NCT00405782·Boston, Massachusetts and 1 other

CompletedStudy of the Glutaminase Inhibitor CB-839 in Solid TumorsMany tumor cells, in contrast to normal cells, have been shown to require the amino acid glutamine to produce energy for growth and survival.NCT02071862·San Francisco, California and 12 others

TerminatedBreast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision LumpectomyThis study is being done to find out the number of surgical procedures required to achieve clear margins in women with newly diagnosed early stage breast carcinoma.NCT01568346·Boston, Massachusetts and 2 others

TerminatedStudy Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerThis is a research study in 2 parts assessing the following parameters of the combination of the study drug called bosutinib, and a drug called capecitabine: the safety, how well…NCT00959946·Boston, Massachusetts and 6 others

Active not recruitingELVN-002 in HER2 Mutant Non-Small Cell Lung CancerThe goal of this clinical trial is to test ELVN-002 in people with cancers that have an abnormal HER2 gene.NCT05650879·Aurora, Colorado and 38 others

Active not recruitingPhase IIB Trial of Bazedoxifene Plus Conjugated EstrogensWomen at risk for development of breast cancer and experiencing vasomotor menopausal symptoms (hot flashes) will be randomized to bazedoxifene (BZA) plus conjugated estrogens (CE)…NCT04821141·Duarte, California and 5 others

Active not recruitingA Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerThe main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor…NCT05514054·Daphne, Alabama and 671 others

CompletedA Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerThe purpose of this study is to evaluate the effectiveness of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus physicians choice standard of care…NCT02675231·Bakersfield, California and 92 others

CompletedDose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast CancerThe purpose of this research study is to determine the safety of RAD001 and the highest dose of this drug that can be given to people with HER2-positive metastatic breast cancer…NCT00458237·Boston, Massachusetts and 1 other

PreviousPage 20 of 53Next

Other Conditions in Boston

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma